Abstract
This review highlights an evidence-based approach for patients with paroxysmal atrial fibrillation (PAF) using class IC antiarrhythmic therapy. After ensuring patients are eligible for pill-in-the-pocket (PIP) therapy and after successful trialing of PIP in a monitored environment, nurse practitioners can prescribe an oral atrioventricular nodal blocker, followed by class IC antiarrhythmic therapy, to chemically cardiovert PAF into normal sinus rhythm in an unmonitored out-of-hospital setting. Given the safety and success rates of PIP drugs, this method reduces emergency department visits and hospitalizations and is considered an effective first-line treatment approach to terminate PAF.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
